Profilo
Claudio Dansky Ullmann formerly worked at Takeda Pharmaceutical Co., Ltd., as Senior Medical Director from 2012 to 2015, MaxCyte, Inc., as Chief Medical Officer, Infinity Pharmaceuticals, Inc., as Senior Vice President-Clinical Development, Avenge Bio, Inc., as Chief Medical Officer, and Context Therapeutics, Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Ullmann received his graduate degree from Universidad de Buenos Aires.
Precedenti posizioni note di Claudio Ullmann
| Società | Posizione | Fine |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 10/05/2025 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Direttore Tecnico/Scientifico/R&S | - |
| MAXCYTE, INC. | Direttore Tecnico/Scientifico/R&S | - |
| INFINITY PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Claudio Ullmann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
















